This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignees: Bayer Healthcare LLC, Oklahoma Medical Research Foundation. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2022
Title: **Xiao-Yan Zhao: Innovator in Monoclonal Antibody Research**
Introduction
Xiao-Yan Zhao, an accomplished inventor based in Union City, CA, has made significant contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies. With a total of five patents to his name, Zhao's research focuses on innovative treatments utilizing these antibodies to inhibit activated protein C, presenting new avenues in medical therapies.
Latest Patents
Zhao's recent patents demonstrate his ingenuity and expertise. One of his key inventions is titled "Humanized monoclonal antibodies against activated protein C and uses thereof." This patent describes humanized antibodies that selectively bind to and inhibit activated protein C while avoiding interaction with unactivated protein C. The methods of treatment using these antibodies are extensively detailed. Another notable patent is "Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof." This patent outlines optimized humanized antibodies that target specific epitopes outside the catalytic triad of the active site of activated protein C, further advancing treatment possibilities with these antibodies.
Career Highlights
Throughout his career, Xiao-Yan Zhao has worked with renowned organizations like Bayer Healthcare LLC and the Oklahoma Medical Research Foundation. His experiences in these companies have undoubtedly enriched his understanding and expertise in monoclonal antibody research.
Collaborations
Zhao has collaborated with notable coworkers in his innovative journey, including Ji-Yun Kim and Zhuozhi Wang. These partnerships have played a significant role in fostering creativity and advancing research in their field.
Conclusion
With a robust portfolio of patents and impactful collaborations, Xiao-Yan Zhao continues to push the boundaries of biomedical research. His work on humanized monoclonal antibodies holds promise for developing new therapeutic methods, making him a significant figure in the landscape of biotechnology innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile